Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRAALL 2005: Treatment for Young Adults With Acute Lymphoblastic Leukemia
NCT00327678Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2006
- Primary completion
- Apr 2014
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab, imatinib, cyclophosphamide in acute lymphoblastic leukemia (ALL), sponsored by Assistance publique - Hôpitaux de Paris. Started May 2006; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00327678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327678.